| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 87.35 | 0.57 (+0.66%) | 48.14 - 87.75 | 1.8 million |
Market data as of 4:00PM 05/21/13. Quotes are delayed by at least 15 min.
| Open | 86.94 |
|---|---|
| Previous Close | 86.78 |
| Day's Range | 86.90 - 87.75 |
| Market Cap | 31.4B |
| Avg Volume (10 Day) | 1.9M |
| Price/Earnings (Trailing 12 Mo.) | 23.0x |
| Earnings Per Share (Trailing 12 Mo.) | 3.77 |
| Dividend Yield | 0.15 (0.69%) |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Pass |
| Converting sales to profits? | Pass |
| Shareholder's money handled rationally? | Pass |
| Increased shareholder value? | Pass |
| Consistently increased owner earnings? | Pass |
| Sells at 25% discount to intrinsic value? | Pass |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Fail |
|---|---|
| Room to increase dividends? | Pass |
| Increased earnings over time? | Pass |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Pass |
| Has sufficient liquidity? | Pass |
Thermo Fisher Scientific to Host Analyst Meeting
Business Wire - Wednesday 05/08/2013 9:00 AM ET
Thermo Fisher Scientific to Present at the Bank of America Merrill Lynch 2013 Health Care Conference on May 14, 2013
Business Wire - Tuesday 05/07/2013 9:03 AM ET
Thermo Fisher Scientific Reports First Quarter 2013 Results
Business Wire - Wednesday 04/24/2013 6:00 AM ET
| TMO | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 4.46% | |
| Net Income Growth (1yr) | -8.72% | |
| Total Debt/Equity | 0.46 | |
| LT Debt/Equity | 0.43 | |
| Earnings Yield | 4.35% | |
| Price/Sales | 2.46 |
| Company | Last | Change |
|---|---|---|
| Agilent Technologies Inc | 46.75 | +0.88% |
| Life Technologies Corp | 73.68 | +0.15% |
| Quest Diagnostics Inc | 61.39 | +0.97% |
| Laboratory Corporation of America Holdings | 100.63 | +1.00% |
| Mettler-Toledo International Inc | 223.39 | +0.13% |
Data is delayed by at least 15 min.